Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 20/20 | 1.00 |
| ▸ | CTSK | P43235 | 3/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27377188 | 1.00 | CTSC (1.00) | CTSCCTSKKCNH2 | |
| SCHEMBL27381736 | 0.90 | CTSC (1.00) | CTSCCTSKKCNH2 | |
| SCHEMBL27382213 | 0.86 | CTSC (0.76) | CTSCCTSK | |
| SCHEMBL30738853 | 0.86 | CTSC (0.76) | CTSCCTSK | |
| SCHEMBL27382085 | 0.86 | CTSC (0.81) | CTSCCTSKKCNH2 | |
| SCHEMBL27382090 | 0.86 | CTSC (0.81) | CTSCCTSKKCNH2 | |
| SCHEMBL27382088 | 0.86 | CTSC (0.81) | CTSCCTSKKCNH2 | |
| SCHEMBL2072228 | 0.81 | CTSC (1.00) | CTSCCTSKKCNH2 | |
| SCHEMBL30738922 | 0.80 | CTSC (0.97) | CTSCKCNH2 | |
| SCHEMBL27377178 | 0.80 | CTSC (0.97) | CTSCKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062420-A1 | NOVEL DPP1 INHIBITORS AND USES THEREOF | INSMED INC (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4561565-A2 | NOVEL DPP1 INHIBITORS AND USES THEREOF | Insmed Incorporated (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025059526-A1 | DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2024026433-A2 | NOVEL DPP1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED (US) | 2024-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062420-A1 | NOVEL DPP1 INHIBITORS AND USES THEREOF | DPP4, DPP3, DPP7 | CTSC 7/4885CTSK 1272/4885KCNH2 2268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.